The cGAS-STING pathway has been implicated in various stages of the cancer immune cycle, such as inducing cancer cell death, enhancing antigen processing and presentation, promoting T cell activation and tumor infiltration, and facilitating T cell recognition and clearance of cancer cells. Here, STING1 is linked to cancer.